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MOTONEURONS innervating the skeletal musculature were 
among the first neurons shown to require the presence of their 
target cells to develop appropriatelyl,2. But the characterization 
of molecules allowing motoneuron survival has been difficult. 
Ciliary neurotrophic factor prevents the death of motoneurons3-6, 
but its gene is not expressed during development'. Although the 
presence of a neurotrophin receptor on developing motoneurons8- 1O 
has suggested a role for neurotrophins, none could be shown to 
promote motoneuron survival in vitro3• We report here that brain-
derived neurotrophic factor can prevent the death ofaxotomized 
motoneurons in newborn rats, suggesting a role for this neuro-
trophin for motoneuron survival in vivo. 
The facial nerve of newborn rats was sectioned unilaterally 
at birth and the effects of three neurotrophins (nerve growth 
factor (NGF), brain-derived neurotrophic factor (BDNF) and 
neurotrophin-) (NT-))) assessed 7 days later. This nerve was 
chosen for lesion and local application of neurotrophins as it 
contains only motor nerve fibres at the lesion site. Axons of 
proprioceptive sensory neurons (putative in vivo targets of 
BDNF and NT-) (ref. 11)) were not lesioned (they are anatomi-
cally separated from this nerve) so that indirect effects through 
these cells are unlikely. Motoneurons that constitute the facial 
nucleus were counted on both sides. More than 80% of the 
axotomized moto.neurons are lost when axotomy is done at 
births.12,13. NGF, which has been shown to be ineffective in 
TABLE 1 Motoneuron survival after lesion of the facial nerve in newborn 
rat: effects of neurotrophins 
Treatment 
BSA (n=8) 
NGF (n=7) 
BDNF (n=9) 
NT-3 (n=10) 
Number of surviving neurons ±s.e.m. 
Lesioned side Control side 
844±115 
407±127** 
2,222 ± 446* 
1,221±71* 
4,597±222 
4,294±227 
4,534±129 
4,510±271 
Transsection of the facial nerve was done as described previousll, 
Newborn Wistar rats were anaesthetized by hypothermia, the right facial 
nerve exposed at the foramen stylomastoideum and transsected about 
1 mm distal from this position. Gel foam (Spongostan, gift of K. Unsicker, 
Marburg, Germany) soaked in 30 ILl of PBS containing either 5 ILg of BSA 
(Cohn Fraction V, Sigma) or trophic factor was inserted at the site of lesion. 
Nerve growth factor (2.5 S) was isolated from submaxillary glands of adult 
male mice, as described22, Both recombinant mouse BDNF and NT-3 were 
produced in rabbit kidney cells infected with recombinant vaccinia viruses 
and purified as described23. The skin was sutured by silk (Ethikon 3-0) and 
the animals returned to their mothers. On postnatal day 7 the animals were 
killed by ether overdose and perfused transcardially with 50 ml 4% formal-
. dehyde. Brainstems were dissected, postfixed for 1 hour, rinsed with water, 
and dehydrated with increasing concentrations of ethanol (70-100%). After 
embedding with paraffin, serial sections (7 fJ.m) were made from the whole 
brain stem with a serial section microtome (Reichert-Jung 2050 supercut). 
The sections were stained with cresyl violet (Sigma), and facial motoneurons 
with clearly identifiable nuclei and nucleoli were counted on both sides at 
a magnification x125 in every fifth section as previously described5 . The 
counts were not corrected for split nucleoli. 
Different from BSA-treated animals at P < 0.02* or P < 0.05** (Student's 
t-test, 2-tailed), 
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supporting motoneuron survival in vivo9 , was used as a control 
in addition to BSA. The application of NGF to the' cut end of 
the facial nerve did not prevent the loss of motoneurons. In 
fact, fewer motoneurons were observed on the NGF-treated side 
as compared to BSA-treated animals (P < 0.05, Table 1). 
In contrast to tlte animals treated with NGF, significant sur-
vival ofaxotomized motoneurons was observed when BDNF 
was applied to the transsected facial nerve. On average, about 
50% of the lesioned motoneurons were still alive 1 week after 
lesion (Table 1,) which represents a surplus of 40% in comparison 
to NGF or )1% to BSA. 
The survival of motoneurons was also enhanced following 
NT-) treatment (P < 0.02 versus BSA-treated controls), though 
the effects were substantially smaller than those observed with 
BDNF (Table 1). In both BDNF- and NT-)-treated animals 
the lesioned motoneuron cell bodies were smaller compared t~ 
unlesioned controls and showed typical reactive changes (Fig, 
1). Although the lesioned motoneurons still remained clearly 
identifiable (see Fig, 1), the nuclei were displaced and chroma-
tolysis was pronounced both in BDNF- imd in NT-)-treated 
animals. But compared to control animals treated with BSA-gel 
foam, the nuclei appeared larger (Fig. 1), 
These data show that molecules of the neurotrophin gene 
family can support motoneuron survival in vivo, In previous 
studies using purified motoneurons isolated from the chick 
spinal cord at 6 days of embryonic age, no survival effects could 
be observed with either BDNF or NT-), This was not due to 
inadequate culture conditions, because the combination of 
ciliary neurotrophic factor (CNTF) and basic fibroblast growth 
factor (FGF) added to parallel cultures could rescue essentially 
all neurons3, Among the various explanations for the dis-
crepancy with the present results are the possibility that some 
crucial cofactor, absent in culture, is required for the response 
of the neurotrophins to be seen. This cofactor might be another 
growth factor present in vivo or might be related to the presynap-
tic input of the motoneurons in the spinal cord, Alternatively, 
it is possible that motoneurons isolated from the chick embryo 
are. not yet ~esponsive to the neurotrophins or that they lose 
their responsiveness as a consequence of the isolation procedure, 
In any event, an important difference exists between 
motoneurons and sensory neurons cultured in isolation, in that 
all neurotrophins known so far support (to various degrees) the 
survival of neurons isolated from dorsal root ganglia, 
In contrast to the CNTF gene?, both the NT-) and BDNF 
genes are expressed during embryonic development '4. '6. For 
example, NT-) messenger RNA is expressed at relatively high 
levels in the rat spinal cord between embryonic days 13 and 16, 
its expression decreasing gradually to low levels at birth l5 , Also, 
in situ hybridization studies have revealed that the spinal 
motoneurons themselves express the NT-) gene l5 ,I6 and that 
BDNF expression is seen in neurons of the dorsal root ganglia 
in embryonic mice16• In addition to the central nervous systt;m, 
measurable levels of BDNF mRNA have been detected in ske-
letal muscle14 , as well as a variety of tissues in developing chick 
embryos including the skeletal musculature (K,-H, Herzog and 
Y.-A,B" unpublished results). 
In the context of our results, it is worth noting that in adult 
rats there is substantial transport of radio labelled BDNF, and 
to a lesser extent of NT-), by spinal motoneurons 17, But retro-
grade transport of neurotrophins is not always a reliable 
indicator of a biological response. In particular, retrograde 
transport of labelled NGF can be demonstrated in newborn rats 
(unlike in adults), but NGF does not rescue axotomized 
motoneurons (see ref. 9 and this study). 
Finally, the expression of the BDNF gene is dramatically 
upregulated in the sciatic nerve of the adult rat with a delay of 
at least) days after lesion, suggesting that BDNF might play a 
role in motor axon regeneration 18. In contrast, CNTF is constitu-
tively expressed in high amounts in myelinating Schwann cells 
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FIG. 1 Morphology of facial motoneurons in the 
brainstem of 7-day-old rats after unilateral facial 
nerve section at birth. a, Lesioned side after BONF 
treatment. b, Lesioned side after NT·3 treatment. 
C, lesloned side after NGF treatment. d, Llnlesioned 
contralateral side of the same animal as in a 
e, lesioned side after BSA treatment. f. Lesioned 
side after CNTF (5 ~g) treatment as a positive 
control. Scale bar. 50 ~m. 
of peripheral nerves of the adult ratl'l, After lesion, significant 
quantities of CNTF protein seem to persist for at least 1 week 
in the lesioned nerve and could be available to regenerating 
neurons l 9 . Thus, a plausible scenario after peripheral nerve 
lesion would he that motoneurons are supported first by CNTF 
released from injured Schwann cells and. subsequently by 
BDNF, the latter supporting the regeneration of motor axons 
to the periphery. 
Our findings together with those reponed by Oppenheim et 
al.2o and Van et al. 21 indicate that motoneurons are responsive 
to BDNF in vivo. The observation that BDNF can support the 
survival oflesioned facial motoneurons that would die otherwise 
in the absence of survival factors indicates that this neurotrophin 
could have important functions on motoneurons, and mediate 
the regeneration of motor axons to the periphery after neuronal 
le~ion . , 0 
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